MedTrace Logo

Effect of Simulation Based Safety Mobilization Program on Patient Outcomes

NCT06484270 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2024-08-12

No results posted yet for this study

Summary

The aim of the study was to evaluate the effect of safe mobilization training given to nurses through simulation-based learning method on patient care results.. The main questions it aims to answer are:

Is the safe mobilization training given to nurses by simulation-based learning method effective on the performance of nurses? Is the safe mobilization training given to nurses through simulation-based learning effective on patient outcomes?

Researchers will compare drug ABC to a placebo (a look-alike substance that contains no drug) to see if drug ABC works to treat severe asthma.

Nurse Participants will:

Experimental group: Take simulation based safety mobilization program for 4 weeks Control group: Theoretical education for 1 week (two hours)

Patient Participans will:

He/she mobilized by experimental/control groups nurse and care outcomes are measured for 1 week (once before and after practice)

Conditions

  • Patient Outcomes
  • Simulation Based Learning

Interventions

OTHER

Simulation based safety mobilization program

Nurse participants experienced safe patient mobilization with a simulation-based learning method with a standardized patient for 4 weeks. Patient participants were mobilized safely under the supervision of a nurse and the care results were measured.

Sponsors & Collaborators

  • Istanbul Medipol University Hospital

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
22 Years
Max Age
32 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2024-06-01
Completion
2024-06-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06484270 on ClinicalTrials.gov